Zhejiang, China

Lijun Luo

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Novartis Ag, Zhejiang Jiuzhou Pharmaceutical Co., Ltd.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lijun Luo. Retrieved from https://idiyas.com/inventor/lijun-luo-117bd6b6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lijun Luo: Innovator in NEP Inhibitor Manufacturing

Introduction

Lijun Luo is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceutical manufacturing, particularly in the development of processes for producing intermediates used in NEP inhibitors.

Latest Patents

Lijun Luo holds a patent for a process titled "Process for preparing intermediates useful in the manufacture of NEP inhibitors." This invention relates to a new enantioselective process for producing useful intermediates for the manufacture of NEP inhibitors or prodrugs thereof. Specifically, it focuses on NEP inhibitors that comprise a γ-amino-δ-biphenyl-α-methylalkanoic acid or acid ester backbone. He has 1 patent to his name.

Career Highlights

Throughout his career, Lijun Luo has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Novartis AG and Zhejiang Jiuzhou Pharmaceutical Co., Ltd. His work has contributed to advancements in drug manufacturing processes.

Collaborations

Lijun has collaborated with several professionals in his field, including Hui Zheng and Junhui Wei. These collaborations have further enhanced his research and development efforts.

Conclusion

Lijun Luo's innovative work in the field of NEP inhibitors showcases his expertise and commitment to advancing pharmaceutical manufacturing. His contributions are significant in the ongoing development of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…